Boston Scientific vs Omnicom Group
Side-by-side comparison of AI visibility scores, market position, and capabilities
Marlborough MA cardiac devices leader (NYSE: BSX) $16.7B FY2024 revenue (+18%); Farapulse PFA ablation fastest-growing EP device, WATCHMAN FLX 70%+ LAAC share, competing with Abbott and Medtronic.
About
Boston Scientific Corporation is a Marlborough, Massachusetts-based global medical device company — publicly traded on the New York Stock Exchange (NYSE: BSX) as an S&P 500 Health Care component — developing and commercializing medical devices for minimally invasive diagnosis and treatment of cardiovascular disease, cardiac rhythm management, electrophysiology, urology, endoscopy, and neuromodulation through approximately 48,000 employees in 130 countries. In fiscal year 2024, Boston Scientific reported revenues of $16.7 billion (+18% year-over-year) — driven by the Farapulse pulsed field ablation (PFA) system for atrial fibrillation treatment, WATCHMAN FLX left atrial appendage closure (LAAC) device, and Rhythmia Ultra high-density cardiac mapping — making Boston Scientific the fastest-growing large-cap medical device company and one of the strongest organic growth stories in healthcare. CEO Mike Mahoney has executed acquisitions and organic R&D investment to build a diverse cardiovascular and electrophysiology portfolio: the 2023 acquisition of Apollo Endosurgery ($615 million, flexible endoscopic stapling for minimally invasive procedures) and the 2022 acquisition of Lumenis (surgical laser systems) expanded Boston Scientific beyond the cardiac core. Boston Scientific's strongest 2024 growth driver — Farapulse (pulsed field ablation) — achieved rapid adoption as a new standard-of-care in atrial fibrillation ablation by delivering shorter procedure times (2-hour PFA versus 4-hour radiofrequency ablation) and improved safety profile compared to traditional thermal ablation methods.
Advertising holding company with $15.7B FY2024 revenue; $13.5B IPG merger announced Dec 2024 to create world's largest ad group; Omni AI data platform; BBDO, DDB, TBWA flagship agencies.
About
Omnicom Group is one of the world's largest holding companies for advertising, marketing, and communications services, founded in 1986 through the merger of BBDO, Doyle Dane Bernbach, and Needham Harper Worldwide, and headquartered in New York City. The company trades on NYSE (OMC) and reported $15.7 billion in revenues for FY2024, employing approximately 100,000 professionals across more than 70 countries. CEO John Wren has led Omnicom since 1997, navigating the digital transformation of advertising from traditional media to programmatic, social, and AI-driven marketing. In December 2024, Omnicom announced the planned acquisition of Interpublic Group (IPG) in an all-stock deal valued at approximately $13.5 billion, which if completed would create the world's largest advertising holding company with over $25 billion in combined revenues.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.